Literature DB >> 21210147

Educational paper: screening in cancer predisposition syndromes: guidelines for the general pediatrician.

Alexis Teplick1, Megan Kowalski, Jaclyn A Biegel, Kim E Nichols.   

Abstract

Improvements in our understanding of the genetic basis of human disease and increased utilization of genetic testing have identified a variety of heritable disorders associated with the onset of benign or malignant neoplasms during childhood. In many cases, the optimal management of affected children is dependent upon the early detection and treatment of tumors. Surveillance strategies based on the natural history of these lesions are often complex, requiring clinical examinations and radiologic and laboratory studies that evolve over a patient's lifetime. A general pediatrician may be the first to suspect one of these disorders in a patient, or may be faced with questions regarding genetic testing, cancer risk, and cancer screening. The pediatrician may also coordinate and interpret the results of specific surveillance studies. In this review, we present the genetic etiology, presentation, natural history, and surveillance recommendations for four disparate hereditary tumor predisposing syndromes, including Beckwith-Wiedemann syndrome/idiopathic hemihyperplasia, von Hippel-Lindau disease, Li-Fraumeni syndrome, and rhabdoid tumor/schwannomatosis. These examples are meant to offer the clinician practical recommendations as well as a framework upon which to base the understanding and management of other conditions associated with an increased risk to develop tumors in childhood.

Entities:  

Mesh:

Year:  2011        PMID: 21210147      PMCID: PMC3086787          DOI: 10.1007/s00431-010-1377-2

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  67 in total

1.  Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia.

Authors:  Carol L Clericuzio; Emily Chen; Dawn Elizabeth McNeil; Timothy O'Connor; Elaine H Zackai; Livija Medne; Gail Tomlinson; Michael DeBaun
Journal:  J Pediatr       Date:  2003-08       Impact factor: 4.406

2.  Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1.

Authors:  R Weksberg; J Nishikawa; O Caluseriu; Y L Fei; C Shuman; C Wei; L Steele; J Cameron; A Smith; I Ambus; M Li; P N Ray; P Sadowski; J Squire
Journal:  Hum Mol Genet       Date:  2001-12-15       Impact factor: 6.150

3.  Relative frequency and morphology of cancers in carriers of germline TP53 mutations.

Authors:  J M Birch; R D Alston; R J McNally; D G Evans; A M Kelsey; M Harris; O B Eden; J M Varley
Journal:  Oncogene       Date:  2001-08-02       Impact factor: 9.867

4.  Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: a role for laparoscopic and cortical-sparing surgery.

Authors:  Mercedeh Baghai; Geoffrey B Thompson; William F Young; Clive S Grant; Virginia V Michels; Jon A van Heerden
Journal:  Arch Surg       Date:  2002-06

5.  Successful laparoscopic operation of bilateral pheochromocytoma in a patient with Beckwith-Wiedemann syndrome.

Authors:  L Bémurat; P Gosse; P Ballanger; P Tauzin-Fin; P Barat; D Lacombe; P Lemétayer; J Clémenty
Journal:  J Hum Hypertens       Date:  2002-04       Impact factor: 3.012

6.  Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk.

Authors:  Shih-Jen Hwang; Guillermina Lozano; Christopher I Amos; Louise C Strong
Journal:  Am J Hum Genet       Date:  2003-02-27       Impact factor: 11.025

Review 7.  Germline TP53 mutations and Li-Fraumeni syndrome.

Authors:  J M Varley
Journal:  Hum Mutat       Date:  2003-03       Impact factor: 4.878

8.  Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study.

Authors:  Howard M Katzenstein; Wendy B London; Edwin C Douglass; Marleta Reynolds; Jack Plaschkes; Milton J Finegold; Laura C Bowman
Journal:  J Clin Oncol       Date:  2002-08-15       Impact factor: 44.544

Review 9.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

10.  Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.

Authors:  Magali Olivier; David E Goldgar; Nayanta Sodha; Hiroko Ohgaki; Paul Kleihues; Pierre Hainaut; Rosalind A Eeles
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

View more
  12 in total

1.  Development of the Serum α-Fetoprotein Reference Range in Patients with Beckwith-Wiedemann Spectrum.

Authors:  Kelly A Duffy; Jennifer L Cohen; Okan U Elci; Jennifer M Kalish
Journal:  J Pediatr       Date:  2019-06-22       Impact factor: 4.406

2.  Clinical utility gene card for: Beckwith-Wiedemann Syndrome.

Authors:  Thomas Eggermann; Elizabeth Algar; Pablo Lapunzina; Deborah Mackay; Eamonn R Maher; Marcel Mannens; Irène Netchine; Dirk Prawitt; Andrea Riccio; I Karen Temple; Rosanna Weksberg
Journal:  Eur J Hum Genet       Date:  2013-07-03       Impact factor: 4.246

3.  Pediatric oncology for the general pediatrician: introduction to the Educational series.

Authors:  Koenraad K Norga
Journal:  Eur J Pediatr       Date:  2011-01-11       Impact factor: 3.183

Review 4.  Signs and genetics of rare cancer syndromes with gastroenterological features.

Authors:  William Bruno; Giuseppe Fornarini; Paola Ghiorzo
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

5.  Tumor Screening in Beckwith-Wiedemann Syndrome: Parental Perspectives.

Authors:  Kelly A Duffy; Katheryn L Grand; Kristin Zelley; Jennifer M Kalish
Journal:  J Genet Couns       Date:  2017-12-04       Impact factor: 2.537

6.  Pancreatic surgery in infants with Beckwith-Wiedemann syndrome and hyperinsulinism.

Authors:  Pablo Laje; Andrew A Palladino; Tricia R Bhatti; Lisa J States; Charles A Stanley; N Scott Adzick
Journal:  J Pediatr Surg       Date:  2013-12       Impact factor: 2.545

Review 7.  Germline Genetics and Childhood Cancer: Emerging Cancer Predisposition Syndromes and Psychosocial Impacts.

Authors:  Sarah G Mitchell; Bojana Pencheva; Christopher C Porter
Journal:  Curr Oncol Rep       Date:  2019-08-15       Impact factor: 5.075

Review 8.  Ethical issues in neonatal and pediatric clinical trials.

Authors:  Naomi Laventhal; Beth A Tarini; John Lantos
Journal:  Pediatr Clin North Am       Date:  2012-08-26       Impact factor: 3.278

Review 9.  Surveillance Recommendations for Children with Overgrowth Syndromes and Predisposition to Wilms Tumors and Hepatoblastoma.

Authors:  Jennifer M Kalish; Leslie Doros; Lee J Helman; Raoul C Hennekam; Roland P Kuiper; Saskia M Maas; Eamonn R Maher; Kim E Nichols; Sharon E Plon; Christopher C Porter; Surya Rednam; Kris Ann P Schultz; Lisa J States; Gail E Tomlinson; Kristin Zelley; Todd E Druley
Journal:  Clin Cancer Res       Date:  2017-07-01       Impact factor: 12.531

10.  Tumor screening in Beckwith-Wiedemann syndrome-To screen or not to screen?

Authors:  Jennifer M Kalish; Matthew A Deardorff
Journal:  Am J Med Genet A       Date:  2016-09       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.